Interestingly, IDH mutation status may also be useful for the detection of residual disease and prognostication following treatment; several studies investigating the value of serum 2HG during remission in AML have found that elevated serum 2HG levels actually predict shortened overall survival (55, 58, 59). Here, IDH1 is linked to acute myeloid leukemia.